D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.23 MYR
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Duopharma Biotech Bhd
Net Income Peer Comparison

Comparables:
P
PLABS
A
AHEALTH
R
RHONEMA
Y
YSPSAH
K
KOTRA

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Net Income
myr60.5m
CAGR 3-Years
-10%
CAGR 5-Years
-3%
CAGR 10-Years
4%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Net Income
myr5.3m
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
6%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Net Income
myr114.5m
CAGR 3-Years
19%
CAGR 5-Years
12%
CAGR 10-Years
11%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Net Income
myr21.3m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Net Income
myr48.5m
CAGR 3-Years
40%
CAGR 5-Years
7%
CAGR 10-Years
9%
K
Kotra Industries Bhd
KLSE:KOTRA
Net Income
myr53.2m
CAGR 3-Years
N/A
CAGR 5-Years
20%
CAGR 10-Years
25%

See Also

What is Duopharma Biotech Bhd's Net Income?
Net Income
60.5m MYR

Based on the financial report for Jun 30, 2024, Duopharma Biotech Bhd's Net Income amounts to 60.5m MYR.

What is Duopharma Biotech Bhd's Net Income growth rate?
Net Income CAGR 10Y
4%

Over the last year, the Net Income growth was -26%. The average annual Net Income growth rates for Duopharma Biotech Bhd have been -10% over the past three years , -3% over the past five years , and 4% over the past ten years .

Back to Top